CTIS2022-501413-31-00招募中1 期
Immunogenicity of 9-valent HPV vaccine in immunocompromised children and adolescents - 19042021/22
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 126
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 年龄范围
- 0 至 17（—）
- 性别
- All
入选标准
- •Children or adolescents 9 to <18 years of age, Willing to sign consent/assent form, If HIV positive, under ART and undetectable viral load and CD4 cell count >200/mm3 (at least 6 months), If the patient has received chemotherapy or is a SOT/HSCT recipient, referred for immunizations after adequate immune reconstitution according to routine clinical practice
排除标准
- •Previous history of warts and/or anal cancer., Previous immunization with any HPV vaccine., Age below 9., Patients who for any reason should not be included in the study according to the evaluation of the research team.
研究者
相似试验
招募中
4 期
Immunogenicity of 9-valent HPV VaccineHuman Papilloma Virus InfectionNCT05439083Talia Sainz Costa120
招募中
不适用
Immunogenicity of HPV-vaccination in a reduced-dose scheduleHPV10047438cervical cancerNL-OMON53042RIVM1,305
已完成
不适用
Charting of immune reactivity against HPV in patients with HPV-induced (pre-) malignant lesions: The Circle study 2HPV-induced malignancies1004743810027656cancerNL-OMON47408eids Universitair Medisch Centrum1,000
已完成
不适用
Immunogenicity and duration of immunity in immunosuppressed children vaccinated with Human papillomavirus vaccineACTRN12608000260325The Children's Hospital at Westmead59
进行中（未招募）
1 期
VAC-WARTSHPV vaccineCTIS2024-513671-40-00Assistance Publique Hopitaux De Paris146